← Leaderboards
Lucia R Languino
Yale University
$10,651,281
Attributed
$10,854,629
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $854.9K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,854,629 · 11
By mechanism
R01$7,744,214 · 4
P01$2,402,007 · 2
T32$372,386 · 1
R56$168,602 · 1
R29$123,110 · 1
R13$44,310 · 2
Top collaborators
- Andrew E Aplin2 shared
- Alissa M Weaver1 shared
Most similar at Yale University
Same institution · by research overlap
- Scott A Holley$13,292,598
- Martin A. Schwartz$34,384,106
- Stefan Somlo$20,826,249
- Margaret K Hostetter$41,245,506
- Derek K. Toomre$7,124,112
Others in their field
Top investigators on “Integrins”
- Timothy A Springer · Boston Children'S Hospital$50,095,849
- David A Cheresh · Scripps Research Institute$28,587,859
- Mark Howard Ginsberg · University Of California, San Diego$28,221,483
- Martin A. Schwartz · Yale University$23,274,443
- M. Amin Arnaout · Massachusetts General Hospital$23,064,887
- Edward Franklin Plow · Cleveland Clinic Foundation$22,902,830
Research focus
IntegrinsMediatingPathway InteractionsResponseIn VivoMalignant Neoplasm Of ProstateTumorTumor ProgressionTumor GrowthSignal TransductionSignal PathwayProstate Cancer TherapyCellsMalignant NeoplasmsCancer CellBaseReceptorInsightProstateMouse ModelAffectCell SurfaceRegulationFamily
Grant awards (45)
2024 Extracellular Vesicles Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2024 · TR · contact PI
Training Program in Cancer Biology$142,401
T32 · FY2023 · CA · contact PI
Integrin-mediated mechanisms of prostate cancer progression$351,459
R01 · FY2022 · CA · contact PI
Training Program in Cancer Biology$229,985
T32 · FY2022 · CA · contact PI
Integrin-mediated mechanisms of prostate cancer progression$4,883
R01 · FY2022 · CA · contact PI
Integrin-mediated mechanisms of prostate cancer progression$356,850
R01 · FY2021 · CA · contact PI
Integrin-mediated mechanisms of prostate cancer progression$64,260
R01 · FY2021 · CA · contact PI
Integrin-mediated mechanisms of prostate cancer progression$476,796
R01 · FY2020 · CA · contact PI
Project 2 - Intercellular communication in prostate cancer$284,479
P01 · FY2020 · CA · contact PI
Integrin-mediated mechanisms of prostate cancer progression$59,296
R01 · FY2020 · CA · contact PI
International Society for Extracellular Vesicles Annual Meeting$34,310
R13 · FY2020 · TR
Integrin-mediated mechanisms of prostate cancer progression$346,194
R01 · FY2019 · CA · contact PI
Project 2 - Intercellular communication in prostate cancer$260,138
P01 · FY2019 · CA · contact PI
Integrin-mediated mechanisms of prostate cancer progression$369,820
R01 · FY2018 · CA · contact PI
Project 2 - Intercellular communication in prostate cancer$270,560
P01 · FY2018 · CA · contact PI
Project 2 - Intercellular communication in prostate cancer$274,533
P01 · FY2017 · CA · contact PI
Project 2 - Intercellular communication in prostate cancer$212,054
P01 · FY2016 · CA · contact PI
Beta1 Integrins and IGF-l Receptor in Prostate Cancer$261,235
R01 · FY2015 · CA · contact PI
Integrin Signaling Pathways in Prostate Cancer$320,790
R01 · FY2014 · CA · contact PI
Beta1 Integrins and IGF-l Receptor in Prostate Cancer$253,398
R01 · FY2014 · CA · contact PI
Integrin Signaling Pathways in Prostate Cancer$256,012
R01 · FY2013 · CA · contact PI
Beta1 Integrins and IGF-l Receptor in Prostate Cancer$245,562
R01 · FY2013 · CA · contact PI
Integrin regulation of prostate cancer progression$211,225
P01 · FY2013 · CA · contact PI
Integrin regulation of prostate cancer progression$267,209
P01 · FY2012 · CA · contact PI
Integrin Signaling Pathways in Prostate Cancer$261,715
R01 · FY2012 · CA · contact PI
Beta1 Integrins and IGF-l Receptor in Prostate Cancer$261,235
R01 · FY2012 · CA · contact PI
Integrin Signaling Pathways in Prostate Cancer$261,630
R01 · FY2011 · CA · contact PI
Beta1 Integrins and IGF-l Receptor in Prostate Cancer$260,730
R01 · FY2011 · CA · contact PI
Integrin regulation of prostate cancer progression$200,839
P01 · FY2011 · CA · contact PI
Integrin Signaling Pathways in Prostate Cancer$286,273
R01 · FY2010 · CA · contact PI
Integrin regulation of prostate cancer progression$213,470
P01 · FY2010 · CA · contact PI
Integrin regulation of prostate cancer progression$207,500
P01 · FY2010 · CA · contact PI
Beta1 Integrins and IGF-I Receptor in Prostate Cancer$273,876
R01 · FY2009 · CA · contact PI
Integrin Signaling Pathways in Prostate Cancer$168,602
R56 · FY2009 · CA · contact PI
Beta1 Integrins and IGF-I Receptor in Prostate Cancer$273,876
R01 · FY2008 · CA · contact PI
Beta1 Integrins and IGF-I Receptor in Prostate Cancer$282,093
R01 · FY2007 · CA · contact PI
Beta1 Integrins and IGF-I Receptor in Prostate Cancer$281,839
R01 · FY2006 · CA · contact PI
Beta1 Integrins and IGF-I Receptor in Prostate Cancer$287,955
R01 · FY2005 · CA
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCER$268,710
R01 · FY2005 · CA
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCER$268,710
R01 · FY2004 · CA
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCER$268,710
R01 · FY2003 · CA
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCER$276,315
R01 · FY2002 · CA
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCER$292,665
R01 · FY2001 · CA
MOLECULAR REGULATION OF PROSTATE GROWTH BY INTEGRINS$271,327
R01 · FY2000 · DK
MOLECULAR ANALYSIS OF B1 INTEGRINS$123,110
R29 · FY2000 · CA